TXN and aortic stenosis: We hypothesized that TRX1, a cytosolic and extracellular enzyme with anti-oxidative, anti-apoptotic and anti-inflammatory properties [3], in AS patients is increased in plasma and, together with inflammatory cytokines, correlates with the severity of AS, and TRX1 may serve as a clinical biomarker.